Table 4. The correlation between amino acid mutations at different sites of GyrA and MIC50 (µg/mL) of quinolones.
No. amino acid mutation | No. isolates (n) | Amino acid of GyrA | MIC range (MIC50) | |||||
---|---|---|---|---|---|---|---|---|
83 | 87 | Levofloxacin | Ciprofloxacin | Gatifloxacin | Moxifloxacin | |||
Wild | 21 | – | – | ≤0.25–32 (0.5) | ≤0.25–>32 (0.5) | ≤0.25–16 [1] | ≤0.25–8 (≤0.25) | |
1 | 1 | – | Asp87Gly | 1 | 1 | 1 | 0.5 | |
1 | 50 | Ser83Val | – | 8–16 [8] | 16–>32 [32] | 4->32 [8] | 2–32 [4] | |
1 | 1 | Ser83Tyr | - | 8 | 32 | 32 | 4 | |
2 | 3 | Ser83Phe | Asp87Gly | 32–>32 (>32) | >32 | 16–>32 (>32) | 8–>32 (>32) | |
2 | 59 | Ser83Tyr | Asp87Gly | 8–>32 (>32) | >32 | 8–>32 [32] | 4–>32 [16] |
MIC50, minimal inhibitory concentration for 50% isolates.